• PDF: Delivered by email usually within 12 to 48 UK business hours.

The Future of Cardiovascular Diseases Therapeutics
Market Forecasts to 2015

  • Publication Date:December 2009
  • Publisher:GBI Research
  • Product Type: Report
  • Pages:102

The Future of Cardiovascular Diseases Therapeutics Market Forecasts to 2015

The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

Summary

GBI Research, the leading business intelligence provider, has released its latest research ""The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis."" The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global cardiovascular diseases therapeutics market. The report analyzes the markets for cardiovascular disease therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

The scope of this report includes:

  • Annualized market data for the cardiovascular diseases therapeutics market from 2000 to 2008, forecast forward to 2015
  • Analysis of the leading therapeutic segments including hypertension, dyslipidemia and thrombosis
  • Analysis of the cardiovascular diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
  • Market characterization of the cardiovascular diseases therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns
  • Key drivers and barriers that have a significant impact on the market
  • Coverage of pipeline molecules in various phases of drug development
  • Competitive benchmarking of leading companies. The key companies studied in this report are Novartis AG, Sanofi-aventis, Pfizer Inc and Merck & Co
  • Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global cardiovascular diseases therapeutics market

Reasons to buy

The report will aid Business Development and marketing executives strategizing their product launches. It will allow you to;

  • Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the cardiovascular diseases therapeutics market.
  • Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the cardiovascular diseases therapeutics market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • What's the next big thing in the global cardiovascular diseases therapeutics landscape? - Identify, understand and capitalize.
  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Global Cardiovascular Therapeutics Market: Scope of Research
    • 2.1 Introduction
    • 2.2 GBI Research Report Guidance
  • 3 Global Cardiovascular Therapeutics Market: Market Characterization
    • 3.1 Market Forecasts
    • 3.2 Branded Vs Generics
    • 3.3 Average Cost of Therapy
    • 3.4 Volume
    • 3.5 Usage Patterns
      • 3.5.1 Diseased Population
      • 3.5.2 Treatment Seeking Population
      • 3.5.3 Diagnosis Population
      • 3.5.4 Prescription Population
      • 3.5.5 Usage Patterns
      • 3.5.6 Geographical Distribution
  • 4 Global Cardiovascular Therapeutics Market: US Market
    • 4.1 Market Overview
    • 4.2 Market Forecasts
    • 4.3 Average Cost of Therapy
    • 4.4 Volume
    • 4.5 Usage Patterns
      • 4.5.1 Diseased Population
      • 4.5.2 Treatment Seeking Population
      • 4.5.3 Diagnosis Population
      • 4.5.4 Prescription Population
      • 4.5.5 Usage Patterns
  • 5 Global Cardiovascular Therapeutics Market: European Market
    • 5.1 Market Overview
    • 5.2 Market Forecasts
    • 5.3 Average Cost of Therapy
    • 5.4 Volume
    • 5.5 Usage Patterns
      • 5.5.1 Diseased Population
      • 5.5.2 Treatment Seeking Population
      • 5.5.3 Diagnosis Population
      • 5.5.4 Prescription Population
      • 5.5.5 Usage Patterns
  • 6 Global Cardiovascular Therapeutics Market : Japan Market
    • 6.1 Market Forecasts
    • 6.2 Average Cost of Therapy
    • 6.3 Volume
    • 6.4 Usage Patterns
      • 6.4.1 Diseased Population
      • 6.4.2 Treatment Seeking Population
      • 6.4.3 Prescription Population
      • 6.4.4 Usage Patterns
  • 7 Global Hypertension Therapeutics Market
    • 7.1 Market Forecasts
    • 7.2 Average Cost of Therapy
    • 7.3 Volume
    • 7.4 Usage Patterns
      • 7.4.1 Diseased Population
      • 7.4.2 Treatment Seeking Population
      • 7.4.3 Diagnosis Population
      • 7.4.4 Prescription Population
      • 7.4.5 Usage Patterns
  • 8 Global Dyslipidemia Therapeutics Market
    • 8.1 Market Forecasts
    • 8.2 Average Cost of Therapy
    • 8.3 Volume
    • 8.4 Usage Patterns
      • 8.4.1 Diseased Population
      • 8.4.2 Treatment Seeking Population
      • 8.4.3 Diagnosis Population
      • 8.4.4 Prescription Population
      • 8.4.5 Usage Patterns
  • 9 Global Thrombosis Therapeutics Market
    • 9.1 Market Forecasts
    • 9.2 Volume
    • 9.3 Average Cost of Therapy
    • 9.4 Usage Patterns
      • 9.4.1 Diseased Population
      • 9.4.2 Treatment Seeking Population
      • 9.4.3 Diagnosis Population
      • 9.4.4 Prescription Population
      • 9.4.5 Usage Patterns
  • 10 Global Cardiovascular Therapeutics Market: Market Drivers and Restraints
    • 10.1 Market Drivers
      • 10.1.1 Steady Increase in the Elderly Population
      • 10.1.2 Stable Increase in Incidence Rates for Cardiovascular Diseases
      • 10.1.3 Increase in Awareness Levels of Disease Progression and Etiology
    • 10.2 Market Restraints
      • 10.2.1 Patent Expirations and Entry of Generics Pose a Serious Problem for Primary Manufacturers
      • 10.2.2 Reimbursement Restrictions on Drug Classes for Certain Cardiovascular Disease Drug Classes Restricts the Market Growth
  • 11 Global Cardiovascular Therapeutics Market : Unmet Needs
  • 12 Global Cardiovascular Therapeutics Market : Key Market Trends
    • 12.1 Increase in Disease Incidence and Prevalence Rates
    • 12.2 Product Pipeline
    • 12.3 Advertising and Commercialization
    • 12.4 Regulatory trends – Current Reimbursement Scenario
      • 12.4.1 The Budget Impact on Drug Reimbursements
      • 12.4.2 Reliability of Generic Formulations as a Cost Cutting Measure
  • 13 Global Cardiovascular Therapeutics Market: Competitive Landscape
    • 13.1 Overview
    • 13.2 Market Share Analysis
    • 13.3 Competitive Profiling
      • 13.3.1 Pfizer
      • 13.3.2 Sanofi-Aventis
      • 13.3.3 Merck
      • 13.3.4 Novartis
  • 14 Global Cardiovascular Therapeutics Market: M&A Landscape
    • 14.1 Mergers and Acquisitions
      • 14.1.1 Overview
    • 14.2 Licensing Agreements
      • 14.2.1 Research Phase
      • 14.2.2 Preclinical
      • 14.2.3 Phase I
      • 14.2.4 Phase PI/II
      • 14.2.5 Phase II
      • 14.2.6 Phase III
      • 14.2.7 Filed
  • 15 Global Cardiovascular Therapeutics Market : Appendix
    • 15.1 Market Definitions
    • 15.2 Abbreviations
    • 15.3 Research Methodology
      • 15.3.1 Coverage
      • 15.3.2 Secondary Research
      • 15.3.3 Forecasts
      • 15.3.4 Primary Research
      • 15.3.5 Expert Panels
    • 15.4 Contact Us
    • 15.5 Disclaimer
  • List of Tables
    • Table 1: Global Cardiovascular Therapeutics Market, Historical Revenues ($m), 2000-2008
    • Table 2: Global Cardiovascular Therapeutics Market, Revenue Forecasts ($m), 2008-2015
    • Table 3: Global Cardiovascular Therapeutics Market, Revenue Segmentation, 2000-2008
    • Table 4: Global Cardiovascular Therapeutics Market, Revenue Segmentation, 2008-2015
    • Table 5: Global Cardiovascular Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008
    • Table 6: Global Cardiovascular Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2008-2015
    • Table 7: Global Cardiovascular Therapeutics Market, Historical Figures for Volume, 2000-2008
    • Table 8: Global Cardiovascular Therapeutics Market, Forecasts for Volume, 2008-2015
    • Table 9: Global Cardiovascular Therapeutics Market, Historical Figures for Diseased Population, 2000-2008
    • Table 10: Global Cardiovascular Therapeutics Market, Forecasts for Diseased Population , 2008-2015
    • Table 11: Global Cardiovascular Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008
    • Table 12: Global Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015
    • Table 13: Global Cardiovascular Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008
    • Table 14: Global Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015
    • Table 15: Global Cardiovascular Therapeutics Market, Historical Figures for Prescription Population, 2000-2008
    • Table 16: Global Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2008-2015
    • Table 17: Global Cardiovascular Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008
    • Table 18: Global Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2008-2015
    • Table 19: US Cardiovascular Therapeutics Market, Historical Revenues ($m), 2000-2008
    • Table 20: US Cardiovascular Therapeutics Market, Revenue Forecasts ($m), 2008-2015
    • Table 21: US Cardiovascular Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008
    • Table 22: US Cardiovascular Therapeutics Market, Forecasts for the Average Cost of Therapy ($), 2008-2015
    • Table 23: US Cardiovascular Therapeutics Market, Historical Figures for Volume, 2000-2008
    • Table 24: US Cardiovascular Therapeutics Market, Forecasts for Volume, 2008-2015
    • Table 25: US Cardiovascular Therapeutics Market, Historical Figures for Diseased Population, 2000-2008
    • Table 26: US Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2008-2015
    • Table 27: US Cardiovascular Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008
    • Table 28: US Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015
    • Table 29: US Cardiovascular Therapeutics Market, Historical Figures for Diagnosis Population(000'), 2000-2008
    • Table 30: US Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population(000'), 2008-2015
    • Table 31: US Cardiovascular Therapeutics Market, Historical Figures for Prescription Population, 2000-2008
    • Table 32: US Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2008-2015
    • Table 33: US Cardiovascular Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008
    • Table 34: US Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2008-2015
    • Table 35: European Cardiovascular Therapeutics Market, Historical Revenues ($bn), 2000-2008
    • Table 36: European Cardiovascular Therapeutics Market, Revenue Forecasts ($m), 2008-2015
    • Table 37: European Cardiovascular Therapeutics Market, Historical Figures for Average Cost of Treatment, 2000-2008
    • Table 38: European Cardiovascular Therapeutics Market, Forecasts for Average Cost of Treatment, 2008-2015
    • Table 39: European Cardiovascular Therapeutics Market, Historical Figures for Volume, 2000-2008
    • Table 40: European Cardiovascular Therapeutics Market, Forecasts for Volume, 2008-2015
    • Table 41: European Cardiovascular Therapeutics Market, Historical Figures for Diseased Population, 2000-2008
    • Table 42: European Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2008-2015
    • Table 43: European Cardiovascular Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008
    • Table 44: European Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015
    • Table 45: European Cardiovascular Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008
    • Table 46: European Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015
    • Table 47: European Cardiovascular Therapeutics Market, Historical Figures for Prescription Population, 2000-2008
    • Table 48: European Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2008-2015
    • Table 49: European Cardiovascular Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008
    • Table 50: European Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2008-2015
    • Table 51: Japan Cardiovascular Therapeutics Market, Historical Revenues ($m), 2000-2008
    • Table 52: Japan Cardiovascular Therapeutics Market, Revenue Forecasts ($m), 2008-2015
    • Table 53: Japan Cardiovascular Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008
    • Table 54: Japan Cardiovascular Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015
    • Table 55: Japan Cardiovascular Therapeutics Market, Historical Figures for Volume, 2000-2008
    • Table 56: Japan Cardiovascular Therapeutics Market, Forecasts for Volume, 2008-2015
    • Table 57: Japan Cardiovascular Therapeutics Market, Historical Figures for Diseased Population, 2000-2008
    • Table 58: Japan Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2008-2015
    • Table 59: Japan Cardiovascular Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008
    • Table 60: Japan Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015
    • Table 61: Japan Cardiovascular Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008
    • Table 62: Japan Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015
    • Table 63: Japan Cardiovascular Therapeutics Market, Historical Figures for Prescription Population, 2000-2008
    • Table 64: Japan Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2008-2015
    • Table 65: Japan Cardiovascular Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008
    • Table 66: Japan Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2008-2015
    • Table 67: Global Hypertension Therapeutics Market, Historical Revenues ($m), 2000-2008
    • Table 68: Global Hypertension Therapeutics Market, Revenue Forecasts ($m), 2008-2015
    • Table 69: Global Hypertension Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008
    • Table 70: Global Hypertension Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015
    • Table 71: Global Hypertension Therapeutics Market, Historical Figures for Volume, 2000-2008
    • Table 72: Global Hypertension Therapeutics Market, Forecasts for Volume, 2008-2015
    • Table 73: Global Hypertension Therapeutics Market, Historical Figures for Diseased Population, 2000-2008
    • Table 74: Global Hypertension Therapeutics Market, Forecasts for Diseased Population, 2008-2015
    • Table 75: Global Hypertension Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008
    • Table 76: Global Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015
    • Table 77: Global Hypertension Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008
    • Table 78: Global Hypertension Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015
    • Table 79: Global Hypertension Therapeutics Market, Historical Figures for Prescription Population, 2000-2008
    • Table 80: Global Hypertension Therapeutics Market, Forecasts for Prescription Population, 2008-2015
    • Table 81: Global Hypertension Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008
    • Table 82: Global Hypertension Therapeutics Market, Forecasts for Usage Patterns, 2008-2015
    • Table 83: Global Dyslipidemia Therapeutics Market, Historical Revenues ($m), 2000-2008
    • Table 84: Global Dyslipidemia Therapeutics Market, Revenue Forecasts ($m), 2008-2015
    • Table 85: Global Dyslipidemia Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008
    • Table 86: Global Dyslipidemia Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015
    • Table 87: Global Dyslipidemia Therapeutics Market, Historical Figures for Volume, 2000-2008
    • Table 88: Global Dyslipidemia Therapeutics Market, Forecasts for Volume, 2008-2015
    • Table 89: Global Dyslipidemia Therapeutics Market, Historical Figures for Diseased Population, 2000-2008
    • Table 90: Global Dyslipidemia Therapeutics Market, Forecasts for Diseased Population, 2008-2015
    • Table 91: Global Dyslipidemia Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008
    • Table 92: Global Dyslipidemia Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015
    • Table 93: Global Dyslipidemia Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008
    • Table 94: Global Dyslipidemia Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015
    • Table 95: Global Dyslipidemia Therapeutics Market, Historical Figures for Prescription Population, 2000-2008
    • Table 96: Global Dyslipidemia Therapeutics Market, Forecasts for Prescription Population, 2008-2015
    • Table 97: Global Dyslipidemia Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008
    • Table 98: Global Dyslipidemia Therapeutics Market, Forecasts for Usage Patterns, 2008-2015
    • Table 99: Global Thrombosis Therapeutics Market, Historical Revenues ($m), 2000-2008
    • Table 100: Global Thrombosis Therapeutics Market, Revenue Forecasts ($m), 2008-2015
    • Table 101: Global Thrombosis Therapeutics Market, Historical Figures for Volume, 2000-2008
    • Table 102: Global Thrombosis Therapeutics Market, Forecasts for Volume, 2008-2015
    • Table 103: Global Thrombosis Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008
    • Table 104: Global Thrombosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015
    • Table 105: Global Thrombosis Therapeutics Market, Historical Figures for Diseased Population, 2000-2008
    • Table 106: Global Thrombosis Therapeutics Market, Forecast Figures for Diseased Population, 2008-2015
    • Table 107: Global Thrombosis Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008
    • Table 108: Global Thrombosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015
    • Table 109: Global Thrombosis Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008
    • Table 110: Global Thrombosis Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015
    • Table 111: Global Thrombosis Therapeutics Market, Historical Figures for Prescription Population, 2000-2008
    • Table 112: Global Thrombosis Therapeutics Market, Forecasts for Prescription Population, 2008-2015
    • Table 113: Global Thrombosis Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008
    • Table 114: Global Thrombosis Therapeutics Market, Forecasts for Usage Patterns, 2008-2015
    • Table 115: Global Cardiovascular Therapeutics Market, Market Drivers, 2008
    • Table 116: Global Cardiovascular Therapeutics Market, Market Restraints, 2008
    • Table 117: Global Cardiovascular Therapeutics Market, Major Drug Patent Expirations, 2008-2015
    • Table 118:Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the Research Stage, 2008-2009
    • Table 119: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the Pre-clinical Stage, 2008-2009
    • Table 120: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the PI Stage, 2008-2009
    • Table 121: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the PI/PII Stage, 2008-2009
    • Table 122: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the PII Stage, 2008-2009
    • Table 123: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the PIII stage, 2008-2009
    • Table 124: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the Filed Stage, 2008-2009
  • List of Figures
    • Figure 1: Global Cardiovascular Therapeutics Market, Revenue Forecast, 2000-2015
    • Figure 2: Global Cardiovascular Therapeutics Market, Revenue Segmentation, 2000-2015
    • Figure 3: Global Cardiovascular Therapeutics Market, Average Cost of Therapy ($), | 2000-2015
    • Figure 4: Global Cardiovascular Therapeutics Market, Volume, 2000-2015
    • Figure 5: Global Cardiovascular Therapeutics Market, Global Diseased Population, 2000-2015
    • Figure 6: Global Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015
    • Figure 7: Global Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015
    • Figure 8: Global Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2000-2015
    • Figure 9: Cardiovascular Therapeutics Market, Global, Forecasts for Treatment Patterns, 2000-2015
    • Figure 10: Global Cardiovascular Therapeutics Market, Geographical Distribution of Revenues ($bn), 2000-2015
    • Figure 11: US Cardiovascular Therapeutics Market, Revenue Forecasts ($bn), 2000-2015
    • Figure 12: US Cardiovascular Therapeutics Market, Average Cost of Therapy ($), 2000-2015
    • Figure 13: US Cardiovascular Therapeutics Market, Volume (million), 2000-2015
    • Figure 14: US Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2000-2015
    • Figure 15: US Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015
    • Figure 16: US Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015
    • Figure 17: US Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2000-2015
    • Figure 18: US Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2000-2015
    • Figure 19: European Cardiovascular Therapeutics Market, Revenue Forecasts ($bn), 2000-2015
    • Figure 20: European Cardiovascular Therapeutics Market, Forecasts for Average Cost of Treatment ($), 2000-2015
    • Figure 21: European Cardiovascular Therapeutics Market, Forecasts for Volume, 2000-2015
    • Figure 22: European Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2000-2015
    • Figure 23: European Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015
    • Figure 24: European Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015
    • Figure 25: European Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2000-2015
    • Figure 26: European Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2000-2015
    • Figure 27: Japan Cardiovascular Therapeutics Market, Revenue Forecasts ($bn), 2000-2015
    • Figure 28: Japan Cardiovascular Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015
    • Figure 29: Japan Cardiovascular Therapeutics Market, Forecasts for Volume, 2000-2015
    • Figure 30: Japan Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2000-2015
    • Figure 31: Japan Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015
    • Figure 32: Japan Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015
    • Figure 33: Japan Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2000-2015
    • Figure 34: Japan Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2000-2015
    • Figure 35: Global Hypertension Therapeutics Market, Revenue Forecasts ($bn), 2000-2015
    • Figure 36: Global Hypertension Therapeutics Market, Average Cost of Therapy ($), 2000-2015
    • Figure 37: Global Hypertension Therapeutics Market, Volume, 2000-2015
    • Figure 38: Global Hypertension Therapeutics Market, Forecasts for Diseased Population, 2000-2015
    • Figure 39: Global Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015
    • Figure 40: Global Hypertension Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015
    • Figure 41: Global Hypertension Therapeutics Market, Forecasts for Prescription Population, 2000-2015
    • Figure 42: Global Hypertension Therapeutics Market, Forecasts for Usage Patterns, 2000-2015
    • Figure 43: Global Dyslipidemia Therapeutics Market, Revenue Forecasts ($bn), 2000-2015
    • Figure 44: Global Dyslipidemia Therapeutics Market, Average Cost of Therapy ($), 2000-2015
    • Figure 45: Global Dyslipidemia Therapeutics Market, Volume, 2000-2015
    • Figure 46: Global Dyslipidemia Therapeutics Market, Forecasts for Diseased Population, 2000-2015
    • Figure 47: Global Dyslipidemia Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015
    • Figure 48: Global Dyslipidemia Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015
    • Figure 49: Global Dyslipidemia Therapeutics Market, Forecasts for Prescription Population, 2000-2015
    • Figure 50: Global Cardiovascular Therapeutics Market, Forecasts for Treatment Patterns, 2000-2015
    • Figure 51: Global Thrombosis Therapeutics Market, Revenue Forecasts ($bn), 2000-2015
    • Figure 52: Global Thrombosis Therapeutics Market, Volume, 2000-2015
    • Figure 53: Global Thrombosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015
    • Figure 54: Global Thrombosis Therapeutics Market, Forecasts for Diseased Population, 2000-2015
    • Figure 55: Global Thrombosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015
    • Figure 56: Global Thrombosis Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015
    • Figure 57: Global Thrombosis Therapeutics Market, Forecasts for Prescription Population, 2000-2015
    • Figure 58: Global Thrombosis Therapeutics Market, Forecasts for Treatment Patterns, 2000-2015
    • Figure 59: Global Cardiovascular Disease Therapeutics Market, Market Indicators, 2008
    • Figure 60: Global Cardiovascular Therapeutics Market, Analysis of Unmet Needs for Major Disease Sectors, 2008
    • Figure 61: Global Cardiovascular Disease Therapeutics Market, Key Market Events, 2008-2015
    • Figure 62: Global Cardiovascular Therapeutics Market, Market Share of Top Manufacturers, 2008
    • Figure 63: Global Cardiovascular Therapeutics Market, Benchmarking Analysis for Top Four Manufacturers, 2008
    • Figure 64: Global Cardiovascular Therapeutics Market, Benchmarking Analysis for Top Four Manufacturers Pipeline and Unmet Need Analysis, 2008
    • Figure 65: Global Cardiovascular Therapeutics Market, M&A Deals by Geography, 2008
    • Figure 66: Global Cardiovascular Therapeutics Market, M&A Deals by Deal Size, 2008
    • Figure 67: Global Cardiovascular Therapeutics Market, M&A Deals by Phase, 2008
    • Figure 68: Global Cardiovascular Therapeutics Market, Top Three M&A Deals, 2008
    • Figure 69: Global Cardiovascular Therapeutics Market, Licensing Agreement by Geography, 2008
    • Figure 70: Global Cardiovascular Therapeutics Market, Licensing Agreement by Deal Size, 2008
    • Figure 71: Global Cardiovascular Therapeutics Market, Licensing Agreements by Phase of Development, 2008
    • Figure 72: Global Cardiovascular Therapeutics Market, Licensing Agreement by Indications, 2008
    • Figure 73: GBI Research Methodology
    • Figure 74: GBI Research Market Forecasting Methodology
+44 20 8816 8548

Ask a question about The Future of Cardiovascular Diseases Therapeutics

Enter the characters you see in the picture below
Captcha